Patricia Bitar
Direktor/Vorstandsmitglied bei Memgen, Inc.
Aktive Positionen von Patricia Bitar
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Patricia Bitar
Ehemalige bekannte Positionen von Patricia Bitar
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
LANDOS BIOPHARMA, INC. | Finanzdirektor/CFO | 06.11.2021 | 15.05.2022 |
TRACON PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 01.09.2014 | 15.06.2018 |
Treasurer | 01.09.2014 | 15.06.2018 | |
NUVASIVE, INC. | Comptroller/Controller/Auditor | 01.11.2009 | 01.04.2014 |
OREXIGEN THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01.01.2006 | 01.01.2008 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.01.1994 | 01.01.1998 |
Ausbildung von Patricia Bitar
University of West Florida | Graduate Degree |
Old Dominion University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Vereinigtes Königreich | 2 |
Operativ
Director of Finance/CFO | 2 |
Comptroller/Controller/Auditor | 2 |
Treasurer | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
TRACON PHARMACEUTICALS, INC. | Health Technology |
LANDOS BIOPHARMA, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
NuVasive, Inc.
NuVasive, Inc. Medical SpecialtiesHealth Technology NuVasive, Inc. engages in the development, manufacture, sale, and provision of procedural solutions for spine surgery. It offers a comprehensive portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. The company was founded by Alexis V. Lukianov on July 21, 1997 and is headquartered in San Diego, CA. | Health Technology |
Orexigen Therapeutics, Inc.
Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Health Technology |
- Börse
- Insiders
- Patricia Bitar
- Erfahrung